I saw this in emails I get from Nature Briefing. I'm not too familiar with them yet. I'm having a difficult time trying too figure out what is happening with Covid. Many countries are losening restrictions yet the disease and it's variants seem quite active and presenting needs for treatments. I hope that by the time that RVX gets anything done that there is still a need for apabetalone for Covid.

Toinv

Nature Briefing Feb 17 2022

COVID reinfections surge during Omicron

Since the Omicron variant of SARS-CoV-2 was first detected, the number of people reinfected with the coronavirus has been rising sharply — a trend that was not observed with previous variants. Scientists say the new variant is probably driving the surge because it can evade the body’s immune defences. And research has shown that immunity acquired through previous infection is less effective against Omicron than against other variants, but the risk of severe COVID-19 remains low.

Nature | 4 min read
References: NEJM paper